No Data Available
Chemo Pharma - Starsource Multitrade Share Price
BSE
Loading...
| Open | - |
| High | - |
| Low | - |
| Prev Close | - |
| Volume | - |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | -1.16 |
| EPS - TTM(₹) | -79.10 |
| MCap(₹ Cr.) | 13.80 |
| MCap Rank | 177 |
| PB Ratio(x) | 11.50 |
| Div Yield(%) | - |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 152.90 |
| 52W Low(₹) | 75.00 |
| MCap/Sales | 31.74 |
| Beta(1 Month) | 0.02 |
| BV/Share(₹) | 8.60 |
Chemo Pharma share price insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 16.9% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Chemo Pharma Share Price Update
Starsource Multitrade Ltd. share price moved down by -0.16% from its previous close of Rs 92.15. Starsource Multitrade Ltd. stock last traded price is 92.00
Share Price Value Today/Current/Last 92.00 Previous Day 92.15
Found Insights useful?
Chemo Pharma Share Price Returns
| 1 Day | -0.16% |
| 1 Month | -19.65% |
| 3 Months | -8.85% |
| 1 Year | -21.74% |
| 3 Years | 155.56% |
| 5 Years | 240.74% |
Chemo Pharma Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
News & Analysis
News
Community boiler pioneer Steamhouse India files UDRHP with Sebi for Rs 425 cr IPO
News
Corporate Radar: Microcap stock to trade ex-bonus in 3:1 ratio & more
News
Ahead of Market: 12 things that will decide stock action on TuesdayResult-Audited Financial Result For The Fourth Quarter And Year Ended On March 31, 20..
Announcements
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income 0.00 0.00 0.53 0.02 -0.16 Total Income Growth (%) - -100.00 2,439.61 -112.61 10.28 Total Expenses 0.07 0.09 0.43 11.83 0.02 Total Expenses Growth (%) -16.58 -79.77 -96.38 0.01 -24.23 EBIT -0.07 -0.09 0.10 -11.80 -0.18 EBIT Growth (%) - -188.19 - - - Profit after Tax (PAT) -0.07 -0.09 0.10 -11.81 -0.34 PAT Growth (%) - -188.28 - - - EBIT Margin (%) 0.00 - 18.66 -0.01 112.00 Net Profit Margin (%) 0.00 - 18.64 -0.01 206.95 Basic EPS (₹) -0.48 -0.58 0.65 -78.70 -2.26 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 16.9% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 1.81 13.35 13.02 11.62 11.66 Total Assets Growth (%) -86.44 2.53 12.05 -0.34 5.52 Total Liabilities 0.52 0.21 0.21 0.02 0.11 Total Liabilities Growth (%) 147.62 0.00 950.00 -81.82 83.33 Total Equity 1.29 13.14 12.80 11.60 11.55 Total Equity Growth (%) -90.18 2.66 10.34 0.43 5.10 Current Ratio (x) 3.50 52.70 35.10 306.67 58.17 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 0.00 - - - 0.11 All figures in Rs Cr, unless mentioned otherwise
InsightsZero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities -10.62 -0.28 0.72 -0.68 -0.33 Net Cash used in Investing Activities 0.01 10.46 -0.52 0.63 0.97 Net Cash flow from Financing Activities 0.00 -0.16 -0.15 -0.08 -2.12 Net Cash Flow -10.61 10.02 0.05 -0.13 -1.49 Closing Cash & Cash Equivalent 0.01 10.62 0.61 0.56 0.69 Closing Cash & Cash Equivalent Growth (%) -99.89 1,653.46 8.99 -18.96 -93.69 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) -919.20 2.60 9.37 0.40 4.84 Return on Capital Employed (%) -914.65 3.78 12.80 0.63 3.15 Return on Assets (%) -654.32 2.56 9.22 0.40 4.80 Interest Coverage Ratio (x) 0.00 0.00 0.00 0.00 0.00 Asset Turnover Ratio (x) 0.07 - - - - Price to Earnings (x) -1.41 54.64 8.12 128.21 11.07 Price to Book (x) 12.94 1.42 0.76 0.52 0.54 EV/EBITDA (x) -1.41 16.02 2.21 -0.82 0.02 EBITDA Margin (%) -2,255.00 0.00 0.00 0.00 0.00
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
No Data Available
Chemo Pharma Top Searches
Corporate Actions
Board Meeting
Audited Results
May 25, 2026
Board Meeting
Quarterly Results
Feb 09, 2026
Board Meeting
Quarterly Results
Nov 10, 2025
Announced on Meeting on May 25, 2026 May 29, 2026 Audited Results Feb 09, 2026 Feb 12, 2026 Quarterly Results Nov 10, 2025 Nov 13, 2025 Quarterly Results Aug 14, 2025 Aug 22, 2025 Others Aug 05, 2025 Aug 12, 2025 Quarterly Results & A.G.M. No Data Available
No Data Available
No Data Available
Announced on Ex-Date Sep 30, 1991 Oct 08, 1991 Rights ratio: 1 share for every 2 held at a price of Rs 10.0 Announced on Meeting on Aug 29, 2025 Sep 24, 2025 - Jul 29, 2024 - Book closure from Sep 17, 2024 to Sep 23, 2024 Jul 29, 2024 - Book closure from Sep 17, 2024 to Sep 23, 2024 Jul 29, 2024 - Book closure from Sep 17, 2024 to Sep 23, 2024 Jul 29, 2024 - Book closure from Sep 17, 2024 to Sep 23, 2024
About Chemo Pharma
Industry
Key Indices Listed On
-
Address
5, Kumud Apartment CHS Ltd.,Karnik Road, Chikan Ghar,Kalyan,Thane District, Maharashtra - 421301
Executive Leadership
RM
Ruchit Mehta
Managing Director & CEOUT
Utsav Trivedi
Executive Director & CFOSG
Sarvagya Goel
Non.ExeInd.DirectorSC
Shilpi Chopra
Non.ExeInd.DirectorShow More
Auditors
Sanjay Rane & Associates
VMD & Co
FAQs about Chemo Pharma share
- 1. What's Chemo Pharma share price today and what are Chemo Pharma share returns ?Chemo Pharma share price is Rs 92.00 as on 25 Jun, 2026, 12:16 PM IST. Chemo Pharma share price is down by 0.16% based on previous share price of Rs 96.25. Chemo Pharma share price trend:
- Last 3 Years: Chemo Pharma Share price moved up by 155.56%
- 2. What are the returns for Chemo Pharma share?Return Performance of Chemo Pharma Shares:
- 1 Week: Chemo Pharma share price moved down by 11.96%
- 3. What is 52 week high/low of Chemo Pharma share price?In last 52 weeks Chemo Pharma share had a high price of Rs 152.90 and low price of Rs 75.00
- 4. What's the market capitalization of Chemo Pharma?Market Capitalization of Chemo Pharma stock is Rs 13.80 Cr.
- 5. What is the PE & PB ratio of Chemo Pharma?The PE ratio of Chemo Pharma stands at -1.25, while the PB ratio is 11.5.
Top Gainers
As on 12:41 PM | 25 Jun 2026Top Losers
As on 12:41 PM | 25 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.